Deep Neuromuscular Blockade in Laparoscopic One-Anastomosis Gastric Bypass (OAGB): A Randomized Controlled Trial - Takeaways - MDSpire

Deep Neuromuscular Blockade in Laparoscopic One-Anastomosis Gastric Bypass (OAGB): A Randomized Controlled Trial

  • By

  • Nikolas Drakos

  • Stella Antoniou

  • Ioannis D. Kostakis

  • Diamanto Aretha

  • Sofia Bregianni

  • Christina Kalogeropoulou

  • George Skroubis

  • June 16, 2026

  • 0 min

Share

  • 1

    This study evaluates deep neuromuscular blockade (NMB) during laparoscopic one-anastomosis gastric bypass surgery.

  • 2

    Participants were randomly assigned to either deep or moderate NMB groups, with surgical conditions assessed using the Leiden Surgical Rating Scale.

  • 3

    The study monitored intraoperative pulmonary mechanics and hemodynamic parameters, alongside immediate postoperative complications.

  • 4

    Patients received multimodal analgesia and were monitored for pain scores and respiratory complications in the Post Anesthesia Care Unit.

  • 5

    The trial was conducted from August 2024 to June 2025, with ethical approval and informed consent obtained from all participants.

Original Source(s)

Deep Neuromuscular Blockade in Laparoscopic One-Anastomosis Gastric Bypass (OAGB): A Randomized Controlled Trial

  • by Nikolas Drakos, Stella Antoniou, Ioannis D. Kostakis, Diamanto Aretha, Sofia Bregianni, Christina Kalogeropoulou, George Skroubis

  • June 16, 2026

Related Content

Artificial intelligence in neurovascular surgery: advancing diagnosis, treatment, and outcomes

European consensus on pre-operative imaging in breast cancer developed jointly by EUSOBI, ESSO, ESP and ESTRO

Efficacy of different nerve block techniques with liposomal bupivacaine for postoperative analgesia in patients undergoing single-port video-assisted thoracoscopic partial lung resection